Why the study?
Obesity increases male cardiovascular risk through mechanisms including low-grade chronic inflammation and hypogonadism, but the effects of metabolic surgery on carotid intima-media thickness via changes in biomarkers and testosterone remain to be evaluated.
Does metabolic surgery reduce carotid intima-media thickness and improve inflammatory biomarkers in men with obesity compared to lifestyle modification?
Does metabolic surgery reduce carotid intima-media thickness and improve inflammatory biomarkers in men with obesity compared to lifestyle modification?
Metabolic surgery (RYGB or SG) significantly reduces carotid intima-media thickness and improves inflammatory and endothelial biomarkers at 6 months in men with obesity compared to lifestyle modification alone.
Answers are grounded in this paper and cite their sources.
Metabolic surgery may improve carotid IMT in obese men via biomarker shifts; leaves open whether changes alter CV events.
Obesity increases cardiovascular risk in men through several mechanisms. Among them, low-grade chronic inflammation and obesity-associated hypogonadism have been described. We aimed to study the effects of metabolic surgery on the carotid-intima media thickness through changes in inflammatory, endothelial biomarkers, and testosterone. We included 60 men; 20 submitted to laparoscopic Roux-en-Y gastric bypass (RYGB), 20 to sleeve gastrectomy (SG), and 20 to lifestyle modification (controls). Several inflammatory and endothelial biomarkers and total testosterone (TT) were measured at baseline and six months after surgery. Free testosterone (FT) was calculated, and carotid intima-media thickness (cIMT) was measured by ultrasonography. Compared to controls, cIMT decreased after surgery concomitantly with CRP, PAI-1, sICAM-1, and IL-18 (p < 0.01) and with an increase in sTWEAK (p = 0.027), with no differences between RYGB and SG. The increase in TT and FT after surgery correlated with the changes in cIMT (p = 0.010 and p = 0.038, respectively), but this association disappeared after multivariate analysis. Linear regression showed that sTWEAK (ß = −0.245, p = 0.039), PAI-1 (ß = 0.346, p = 0.005), and CRP (ß = 0.236, p = 0.049) were associated with the changes in cIMT (R2 = 0.267, F = 6.664, p = 0.001). In conclusion, both RYGB and SG induced improvements in inflammation and endothelial biomarkers that drove a decrease in cIMT compared to men with obesity who submitted to diet and exercise.
No takes yet. Share an insight, caveat, or question.
Cobeta et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: